HealthNexus Data challenge

Antimicrobial resistance (AMR) is one of the most urgent global health threats of our time, compromising our ability to treat common infectious diseases and leading to prolonged illness, disability, and death. Surveillance of AMR data provides critical insights into how resistance patterns are evolving across regions, pathogens, and time. Insights that are essential for effective clinical decision-making and public health interventions.

Our team has selected the “Global Evaluation of Antimicrobial Resistance via Surveillance” dataset to analyze AMR trends for a specific pathogen of public health importance. By focusing on pathogen-specific resistance trends across multiple geographies and timeframes, our research aims to uncover meaningful patterns in antimicrobial susceptibility, detect emerging resistance hotspots, and evaluate the effectiveness of current antimicrobial usage policies. By identifying shifts in resistance patterns, especially for pathogens associated with high morbidity or mortality, our research will support more accurate empirical treatment decisions. This ensures that patients receive the most effective antimicrobial agents sooner, reducing treatment failures, length of hospital stays, and mortality rates. Our pathogen-specific analysis will provide evidence to refine antimicrobial stewardship protocols. By mapping resistance trajectories, clinicians and pharmacists can be better equipped to limit the use of ineffective drugs, minimize unnecessary antibiotic use, and delay the emergence of resistance. The results of this research will help public health authorities design targeted interventions based on local and regional resistance data. It can inform policy decisions regarding infection prevention strategies, drug procurement priorities, and outbreak preparedness.

By demonstrating how surveillance data can be harnessed to generate actionable insights, our study supports the integration of data-driven decision-making into routine health system operations. This contributes to building more resilient health systems capable of responding proactively to AMR threats.

In summary, our project bridges microbiological data with public health policy, contributing to global efforts to curb AMR. Through rigorous, pathogen-specific analysis, we aim to generate knowledge that not only enhances clinical care but also reinforces systems-level responses to antimicrobial resistance.